Judge Schedules First 3 Trials In Abilify MDL

By Nathan Hale (March 13, 2018, 8:54 PM EDT) -- A Florida federal court settled upon a random order for the first three cases that will be tried in multidistrict litigation over side effects of the antipsychotic drug Abilify after consumers who brought the suits were unable to reach an agreement with the drugmakers Bristol-Meyers Squibb and Otsuka Pharmaceutical....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!